MicroRNAs (miRNAs) have gained significant attention in the field of biomarker research due to their potential role in various diseases, including cancer, cardiovascular diseases, and neurological disorders. However, the credibility of miRNA biomarker studies has come under scrutiny in recent years, with a growing number of articles being retracted due to issues such as data manipulation, lack of reproducibility, and ethical concerns.
A recent study published in the journal Nature Communications examined the frequency of citations in future research for retracted miRNA biomarker articles. The researchers analyzed a total of 50 retracted articles that were originally published between 2008 and 2018 and compared their citation rates to a control group of non-retracted articles.
The results of the study revealed that retracted miRNA biomarker articles continued to be cited in future research, with an average of 7.2 citations per retracted article compared to 11.4 citations per non-retracted article. This finding raises concerns about the impact of retracted articles on the scientific community and the potential for misinformation to be perpetuated in the literature.
One possible explanation for the continued citation of retracted miRNA biomarker articles is the lack of awareness among researchers about the retraction status of these studies. In many cases, retracted articles are not clearly marked as such in databases and may still appear in literature reviews and meta-analyses, leading to their continued use as references in new research.
Another factor that may contribute to the citation of retracted articles is the pressure to publish in academia. Researchers are often judged based on their publication record, and the inclusion of high-impact articles in their bibliography can enhance their reputation and career prospects. As a result, some researchers may be tempted to cite retracted articles without thoroughly vetting their credibility.
To address this issue, it is essential for journals and databases to clearly mark retracted articles and provide information about the reasons for retraction. Additionally, researchers should exercise caution when citing previous studies and verify the validity of the findings before incorporating them into their own research.
In conclusion, the frequency of citations in future research for retracted miRNA biomarker articles highlights the need for greater transparency and accountability in scientific publishing. By raising awareness about the pitfalls of citing retracted articles and promoting a culture of integrity and rigor in research, we can ensure that the scientific literature remains a reliable source of knowledge for future generations.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: Plato Data Intelligence.
- Source Link: https://platohealth.ai/how-often-are-retracted-microrna-biomarker-articles-cited-in-future-research/
Takeda’s Iclusig (ponatinib) Receives U.S. FDA Approval for Adult Patients with Newly Diagnosed Ph+ ALL
Takeda Pharmaceutical Company Limited recently announced that its drug Iclusig ponatinib has received approval from the U S Food and...